» Authors » Andrea Roveda

Andrea Roveda

Explore the profile of Andrea Roveda including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 136
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pizzi R, Gini G, Caiano L, Castelli B, Dotan N, Magni F, et al.
Thromb Res . 2020 Sep; 196:209-212. PMID: 32911392
Background: In the recent outbreak of COVID-19 pandemic, increased D-dimer levels and high rates of venous thromboembolic events were reported. We aimed to compare coagulation parameters on admission between COVID-19...
2.
Bagnasco F, Di Iorgi N, Roveda A, Gallizia A, Haupt R, Maghnie M
Endocr Pract . 2017 Jun; 23(8):929-941. PMID: 28614005
Objective: To evaluate the self-reported prevalence of poor adherence to recombinant human growth hormone (rhGH) therapy in a large, representative sample of Italian children and adolescents and to assess treatment...
3.
Aliberti S, Tobaldini E, Giuliani F, Nunziata V, Casazza G, Suigo G, et al.
Respir Res . 2016 Aug; 17(1):98. PMID: 27491412
Background: Alterations of cardiac autonomic control (CAC) are associated with poor outcomes in patients with infectious and non-infectious diseases. No evaluation of CAC in patients with community-acquired pneumonia (CAP) has...
4.
Isgro A, Paciaroni K, Gaziev J, Sodani P, Gallucci C, Marziali M, et al.
Niger Med J . 2015 Aug; 56(3):175-9. PMID: 26229224
Background: Sickle cell anaemia (SCA) remains associated with high risks of morbidity and early death. Children with SCA are at high risk for ischaemic stroke and transient ischaemic attacks, secondary...
5.
Paciaroni K, De Angelis G, Gallucci C, Alfieri C, Ribersani M, Roveda A, et al.
Mediterr J Hematol Infect Dis . 2015 Jan; 7(1):e2015006. PMID: 25574365
Sickle Cell Anaemia (SCA) is the most common inherited blood disorder and is associated with severe morbidity and decreased survival. Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) is the only curative...
6.
Marziali M, Isgro A, Sodani P, Gaziev J, Fraboni D, Paciaroni K, et al.
Mediterr J Hematol Infect Dis . 2014 Nov; 6(1):e2014066. PMID: 25408852
Allogeneic cellular gene therapy through hematopoietic stem cell transplantation is the only radical cure for congenital hemoglobinopathies like thalassemia and sickle cell anemia. Persistent mixed hematopoietic chimerism (PMC) has been...
7.
Isgro A, Sodani P, Marziali M, Gaziev J, Fraboni D, Paciaroni K, et al.
Mediterr J Hematol Infect Dis . 2014 Jul; 6(1):e2014054. PMID: 25045462
Background And Purpose: Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment for sickle cell anemia (SCA). We report our experience with transplantation in children with the Black...
8.
Sodani P, Isgro A, Gaziev J, Paciaroni K, Marziali M, Simone M, et al.
Pediatr Rep . 2011 Nov; 3 Suppl 2:e13. PMID: 22053275
No abstract available.
9.
Isgro A, Marziali M, Sodani P, Gaziev J, Erer B, Polchi P, et al.
Biol Blood Marrow Transplant . 2010 Jun; 16(11):1557-66. PMID: 20546907
To analyze immunohematologic reconstitution, particularly of natural killer (NK) cells, we evaluated 13 β-thalassemia patients after 20 and 60 days and 1 year posttransplantation with T cell-depleted HLA-haploidentical stem cells....
10.
Gaziev J, Paba P, Miano R, Germani S, Sodani P, Bove P, et al.
Biol Blood Marrow Transplant . 2009 Dec; 16(5):662-71. PMID: 20026413
Little is known about late-onset hemorrhagic cystitis (HC) in children, its relationship to BK virus, and treatment with cidofovir (CDV) following hematopoietic stem cell transplantation (HSCT). We prospectively investigated BK...